roche upbeat on avastin in ovarian cancer
roche holding ag, the world's leader in oncology drugs, struck an upbeat tone about approval prospects for its key drug avastin in ovarian cancer ahead of an important industry meeting next month.
http://feeds.reuters.com/~r/reuters/healthnews/~3/hympvviorri/us-roche-idustre74p5kz20110526
25277
26 May 2011 18:42:33
reuters
health